By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GTx, Inc. 

3 N. Dunlap Avenue, Third Floor

Memphis  Tennessee  38163  U.S.A.
Phone: 901-523-9700 Fax: 901-523-9772



Company News
GTx, Inc. (GTXI) Announces Acceptance Of An Abstract On Preliminary Results From Phase II Clinical Trial In Women With Stress Urinary Incontinence At The International Continence Society Annual Meeting 5/11/2017 6:43:28 AM
GTx, Inc. (GTXI) Announces Results From Preclinical Studies Of Sarms In Duchenne Muscular Dystrophy Models Published In Human Molecular Genetics 5/3/2017 6:43:34 AM
GTx, Inc. (GTXI) Provides Corporate Update And Reports Fourth Quarter And Year-End 2016 Financial Results 3/15/2017 7:14:20 AM
GTx, Inc. (GTXI) To Report Fourth Quarter And Full Year 2016 Financial Results On March 15, 2017 3/7/2017 6:24:36 AM
GTx, Inc. (GTXI) Announces 1-for-10 Reverse Stock Split 12/5/2016 11:26:21 AM
GTx, Inc. (GTXI) Release: Enobosarm Meets Pre-Specified Primary Efficacy Endpoint In Ongoing Phase 2 Clinical Trial In ER+/AR+ Breast Cancer 11/28/2016 12:40:44 PM
GTx, Inc. (GTXI) Provides Corporate Update and Reports Third Quarter 2016 Financial Results 11/3/2016 12:02:43 PM
GTx, Inc. (GTXI) Achieves Stage 1 Milestone In Phase II Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer 9/8/2016 11:31:46 AM
GTx, Inc. (GTXI) Announces Webcast Of Corporate Presentation At Baird’s 2016 Healthcare Conference 9/2/2016 10:26:21 AM
GTx, Inc. (GTXI) Appoints Dr. Garry Neil To Board Of Directors 9/1/2016 11:05:24 AM